TABLE 1.
Complex model-derived dosing regimen of amikacin in neonates based on postnatal age and current body weight; in case of ibuprofen co-administration, the dosing interval is prolonged with 10 hours (2, 9)
| Postnatal age (days) | Group | Current weight (grams) | Amikacin dose |
|---|---|---|---|
| <14 | 1 | <800 | 16 mg/kg every 48 hours |
| 3 | 800 to 1,200 | 16 mg/kg every 42 hours | |
| 5 | 1,200 to 2,000 | 15 mg/kg every 36 hours | |
| 7a | 2,000 to 2,800 | 15 mg/kg every 30 hours | |
| 9a | >2,800 | 15 mg/kg every 24 hours | |
| ≥14 | 2 | <800 | 20 mg/kg every 42 hours |
| 4 | 800 to 1,200 | 20 mg/kg every 36 hours | |
| 6 | 1,200 to 2,000 | 18 mg/kg every 30 hours | |
| 8 | 2,000 to 2,800 | 18 mg/kg every 24 hours | |
| 10 | >2,800 | 18 mg/kg every 20 hours |
An additional prolonged dosing interval of +6 hours is suggested for subgroups 7 and 9 in the original publication (9). Since amikacin plasma concentrations were measured without this extended interval, the dosing regimen as listed in this table is used for the current evaluation.